High Grade Dysplasia best practice
Patients with oesophageal glandular High Grade Dysplasia (HGD) are vital to this audit (despite representing only a small fraction of all patients).
We know trusts have difficulty collecting and submitting HGDs - numbers are dropping for the second year in a row - so we are asking trusts with a good submission rate to share their best practice.
We are looking at ways to make things easier for trusts. If your trust would like to share HGD best practice, or raise any issues, then please contact email@example.com
Please also view some general FAQs and a useful NOGCA HGD flowchart on the OG webpage.
We greatly value your input:
"There's no secret to our high submission of HGDs; our CNS and MDT Coordinator sit down once a month and go through the cases."
Christine Day, University Hospital Southampton NHS Foundation Trust
"HGDs which are not on a suspected cancer waits pathway and are not discussed at MDT will not be automatically recorded in our Cancer Database system, so we rely on our clinical teams, like histopathology, to identify missing cases. Data collection and validation is primarily clinically driven with the Consultants and the CNS team working with the MDT Co-ordinator and data team. As a tertiary Oncology centre, we have been able to submit complete data for the cases referred to us for treatment because our network has a shared cancer database system and the Unit Trusts and the Oncology centre work together to complete the data required for submission. Where we refer cases to Trusts outside our network, the Trust data teams liaise to ensure complete and accurate data and the treating Trust then submits the full record. Going forward, we are working on sharing access to our data system with one of these treating trusts."
Susan Young, Maidstone and Tunbridge Wells NHS Trust
"The Cancer Information Manager set up a report to identify HGD patients from our trust's cancer information system. The Clinical Audit Team checks the report and sends the appropriate patients to a key contact in the clinical team, in our case a CNS. We then chase any missing data items or queries on a monthly basis. The CNS also adds any patients missing from the clinical system. We have read-only access to the Leeds cancer information system, which helps when completing treatment data for patients we have referred."
Sandra Halstead, Mid Yorkshire Hospitals NHS Trust